Replies to post #64196 on Amarantus Bioscience Holdings Inc (AMBS)

[blackhawks]

Now there are a whole new set of potential catalysts plus the "fact" that a noted bio-tech analyst states that a current share price of about .20 is realistic without attributing any value to Amarantus Diagnostics.

It's obvious to me that this is overdue for substantial positive news that will double the share price overnight.

I'm hoping to add another million shares before that happens.

We've all seen AMBS pps reaction to the financial analysis.

Clearly some 'investors' were spooked by the time lines to market AND the industry stats for a drug making it to market.

I too am wating for the AMBS JV or the buyout, but I have no illusions that time is short before 'lift off'. I look forward to the support that your intentions to purchase more AMBS shares will provide.

[GS1]

The bio-tech analyst predicted PPS of .20 when they reach revenue of 40 mil. in 2027. Heck we have seen this PPS few weeks ago.

Now you know what analysis you would be getting out of diagnostics also.

i.e 2% market share first year after approval and then will grow in multiples.. simple as that.

But yes, diagnostics will move bit faster than MANF.